Skip to content
Trial Eligibility
Menu

Clinical Transcriptomics in Systemic Vasculitis (CUTIS)

NCT03004326

This study is recruiting at 2 US sites in 2 states, according to its ClinicalTrials.gov record last updated .

Summary

Multi-center observational study to evaluate the histopathology and transcriptome of cutaneous lesions in patients with several different types of vasculitis.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Cryoglobulinemic Vasculitis (CV)
  • Drug-induced Vasculitis
  • Eosinophilic Granulomatosis With Polyangiitis (EGPA)
  • IgA Vasculitis
  • Isolated Cutaneous Vasculitis
  • Granulomatosis With Polyangiitis (GPA)
  • Microscopic Polyangiitis (MPA)
  • Polyarteritis Nodosa (PAN)
  • Urticarial Vasculitis
  • Vasculitis

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
5 years and older
Sex
All
Healthy volunteers
Not accepted
Sponsor
Peter Merkel
Last updated on ClinicalTrials.gov
January 22, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Pennsylvania · 1

  • University of Pennsylvania · Philadelphia, PA

Virginia · 1

  • University of Virginia · Charlottesville, VA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.